BKM120 sensitizes C6 glioma cells to temozolomide via suppression of the PI3K/Akt/NF‑κB/MGMT signaling pathway

Li Mao(Army Medical University), Yan Liu(Carrier (United States))
Oncology Letters
September 22, 2017
Cited by 24


Related Papers